key: cord-0876187-lv43j8vm
authors: Xu, Luming; Yang, Qianqian; Shi, Haojun; Lei, Shijun; Liu, Xiaoli; Zhu, Yin; Wu, Qiulei; Ding, Xiuli; Tian, Yanhong; Hu, Qinghua; Chen, Fenghua; Geng, Zhi; Zeng, Xiangzhi; Lin, Lin; Cai, Xuehong; Wu, Min; Wang, Zehua; Wang, Zheng; Xia, Geqing; Wang, Lin
title: Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates
date: 2020-04-28
journal: Sci Bull (Beijing)
DOI: 10.1016/j.scib.2020.04.040
sha: c33bbfbd7ada7451eb464fbd5c77030f79af54fb
doc_id: 876187
cord_uid: lv43j8vm

nan

The outbreak of COVID-19 has affected the world greatly. While much remains unknown, the severity of the illness is quite alarming. The disease outbreak is still ongoing with a rapidly growing number of patients. With confirmed human-to-human transmission, this disease has put pregnant women at risk, endangering the lives of infected mothers and their babies. However, current data so far have been mainly focused on general population but not for these patients, and we were not sure if SARS-COV-2 can be vertical transmitted from mothers to their babies. Here, we report the clinical, laboratory, radiological profiles and treatment outcomes of these five COVID- 19 pregnant women and provide clinical information of their neonates.

For this retrospective study, five pregnant women were admitted from Jan 21, 2020 to Feb 9, 2020 by Wuhan Union Hospital. All pregnant patients were >34 week pregnancy with fever or respiratory symptoms and all of them were laboratory-confirmed SARS-CoV-2 positive by real-time RT-PCR.

Laboratory confirmation of SARS-CoV-2 infection was done using real time reverse-transcription PCR to amplify ORF1ab gene and N gene (two genes recommended by Chinese Center for Disease Control and Prevention) [2] following the manufacturer's instructions (BioGerm, Shanghai, China).

The tests were performed on a Roche Cobas z480 Automated PCR Analyzer. The sequences for ORF1ab gene amplification and detection were: forward primer The clinical features, laboratory and radiological findings, therapeutic methods and outcomes for all the five patients and their neonates were obtained, recorded and carefully analyzed. All data were checked by three researchers. This study was approved by Wuhan Union Hospital Ethics Committee and informed consent was obtained.

Between Jan 21, 2020 and Feb 9, 2020, five pregnant women were admitted with laboratory-confirmed SARS-CoV-2-infection ( Table 1 and S1). None of them had Huanan seafood market exposure (Table 1 ) and all the patients were residents of Wuhan. According to patients' records, only Patient 4's family member was confirmed with SARS-CoV-2 before onset of her symptoms, and the others did not have Huanan seafood market exposure history or close contact with COVID-19 patients within 14 days before symptoms' onset. These patients were aged between 23-34 years (average 29 years) ( Table 1 ), all of their fetuses were healthy and had normal development during pregnancy. Patient 1 was initially admitted due to obstetric reasons, while Patient 2-5 were admitted due to pneumonia-like symptoms such as fever and dry cough ( According to the definition of illness severity by WHO interim guideline for COVID-19, [3] all the patients developed mild pneumonia and gave birth to babies during hospitalization ( Table 1 ). The time from the onset of symptoms to delivery for these patients was 6 days, 10 days, 5 days, 10 days and 8 days, respectively. Their indicators for baby delivery were: Patient 1 (39w) received C-section due to abdominal pain; Patient 2 (34w+4d), Patient 3 (37w+3d) and 4 (36w+4d) were physiologically ready for parturition through C-section; Patient 5 (37w) had natural laboring due to colporrhagia. None of them had pregnancy terminated due to uncorrectable hypoxemia.

Lymphopenia (<1.1 × 10 9 /L) and eosinopenia (<0.02 × 10 9 /L) were noted in all the patients at the onset of fever. The timing of eosinopenia largely matched that of lymphopenia. Lymphopenia and eosinopenia could persist until patients' illness clinically and radiographically improved after antiviral/ antibacterial treatment. In contrast, leukopenia was observed in only one patient (Patient 1).

Moreover, Patient 2 and 3 had anemia ( Table S1 ). All the patients had decreased albumin, and increased CRP and D-dimer levels (Table S1) , and all the patients were tested negative for other common respiratory infection pathogens (influenza A and B, respiratory syncytial virus, adenoviruses, coxsackie virus, chlamydia pneumonia, and mycoplasma pneumonia) (Table S1 ).

All five patients were subjected to chest CT examination 2-7 days (median 6 days) after the onset of fever ( Figure S1 ), and plumbic suits were covered on their abdomens to protect the fetuses. The CT imaging showed bilateral pneumonia in all five patients with characteristic flake-like or regional ground-glass opacity in segments or lobes ( Figure S1 ; Table S1 ). The opacity was often associated with peripheral lung with no clear subpleural sparing. The CT findings were consistent with early reports. [5, 6] We recorded and analyzed the treatment of five patients (see also supplementary results and discussions; Table S2 ). Notably, Patients 1-5 gave birth to five neonates with the weight ranging from 2.45-3.76 kg ( Table 2) . None of neonates display respiratory infection-related symptoms, including fever, cough, polypnea, dyspnea, cyanosis of lips, and tri-retraction sign at birth. The Apgar scores ranged 7-8 for 1 min, 8-9 for 5 min, and 10 for 10 min (Table 2 ). Once they were born, the neonates were separated from their mothers without breast feeding. The neonate of Patient 1 but not the other neonates had scattered skin rashes in face and body, which was reduced in the next day and gradually disappeared within 7 days. The throat swab specimens from all five neonates were collected at 8, 1, 8, 1, 0 days after birth, respectively, and were all SARS-CoV-2 PCR tested negative (Table 2 ). According to our observation, as of Feb 24, none of these neonates developed any respiratory or systemic symptoms (10-33 days after birth), which were much longer than the currently reported SARS-CoV-2 incubation time (4.1 to 7.0 days, 95% confidence interval). [7] SARS-CoV-2, a new member of the coronavirus family, is a single stranded RNA virus that was first identified in Wuhan, China on Jan 7. Similar to SARS-CoV and MERS-CoV, it can cause severe respiratory illness in infected humans. [8] [9] [10] Early studies revealed that female patients accounted for 32-44% of COVID-19-infected population. [5, 7] Although our pregnant COVID-19 patients (average 29 years, Table 1 ) were younger than affected general adults (average 56 years), [4] they were vulnerable given their immune tolerant conditions during pregnancy. [11] [12] [13] Given that Wuhan has an estimated 120 thousands pregnant women annually, [14] approximately 20,000 of them were currently under COVID-19 infection threat. Given the estimated size doubling-time 7.4 days [7] and the nationwide confirmed over 77,000 cases (as of Feb 24), more pregnant women are expected to be diagnosed. To provide more information on the management of pregnant COVID-19 patients and the vertical transmission of SARS-CoV-2, in this study, we retrospectively analyzed the clinical features of pregnant women with SARS-CoV-2-infected pneumonia and health conditions of their neonates.

Our data revealed some similarities and differences of these pregnant patients compared to general adults. The spectra of symptoms (100% fever vs 82% fever), the rate of conventional oxygen support (100% vs 89%), the rate of antiviral treatment (100% vs 93%) and antibacterial therapy (100% vs 76%), the percentage of patients with increased CRP (100% vs 86%), and the CT imaging characteristics in these pregnant patients were largely comparable to general adults (Table 1 ). [5, 6] In contrast, these women had less underlying diseases than general adults, and exhibited differences in some biochemical markers. Increased D-dimer levels and lymphopenia were observed in all the patients (100%), higher than 36% and 35% in general adults, respectively (Table S1 ). [5] These laboratory differences might be partly due to pregnancy-associated physiological alterations.

Eosinopenia was found to be tightly linked with lymphopenia, which was not reported in early COVID-19 literature, [5] [6] [7] and in SARS-CoV and MERS-CoV infections. [15, 16] In COVID-19 pneumonia, eosinopenia appeared early, at the onset of fever, with a significant reduction (Table S1 ).

Although eosinopenia was reportedly observed in some pregnant women previously, [17] such a drastic decrease in eosinophil counts (reduced to zero in four of five patients) was unusual. Given that lymphopenia was suggestive of diagnosis value for COVID-19 infection [5] and did not commonly appear in normal pregnant women, [18] eosinopenia with early timing feature might be also useful for facilitating early diagnosis. Given that glucocorticosteroids were considered to be one of the major reasons accounting for reduction in the number of eosinophil, [19, 20] it is possible that COVID-19-infection influences the levels of endogenous glucocorticosteroids.

SARS-CoV and MERS-CoV were reported to result in severe complications during pregnancy. [19, 20] In a 12-case study, [21] the 2003 SAS-CoV reportedly caused the death of three women, miscarriage (57%, 4 of 7 first-trimester patients), fetal growth restriction (40%, 2 of 5 second/ third trimester patients), and premature birth (80%, 4 of 5 patients). As for MERS-CoV, it caused even more detrimental outcomes with 91% women (10 of 11 patients) having poor outcomes and 82% neonates having critical conditions and even death. [22] In this study, all the COVID-19 infected patients gave safe birth. The neonates were immediately separated from their mothers once they were born. The skin rashes were observed in one (20%) of the five neonates (Patient 1) (Table 1 and 2). From the birth of these neonates until now, none of these babies developed any respiratory systems or pneumonia-associated symptoms. They seemed not to be locally or systemically impacted by COVID-19 infection in their mothers. This was similarly observed for other coronaviruses, such as SARS-CoV and MERS-CoV-infected mothers and their infants. [21, 23, 24] All neonates' throat swabs were PCR tested negative (Table 2) . Thus, collectively, our observations did not support vertical virus transmission between these five infected mothers and their babies, consistent with a recent study. [1] Meanwhile, to protect neonates from SARS-CoV-2 infections after birth, we recommend prevention measures as follows: the neonates should be immediately isolated for a 14-day medical observation; breast feeding should be avoided; a 14-day isolation is also required for their mothers after discharge.

This study is limited in several aspects. Due to shortage of diagnostics reagents in local hospitals at the early stage of this COVID-19 outbreak, the laboratory-confirmed patient number was not high.

But all patients and neonates in the current study were tested with virus PCR. Although we did not observe vertical transmission in these patients and their neonates, more evidence and further study is still required for further validation. Due to the lack of SARS-CoV-2 antibody detection reagents during this study, the serum IgM of SARS-CoV-2 in neonates, which was a key indicator of new SARS-CoV-2 infection, was not detected. The nucleic acid of SARS-CoV-2 in peripheral blood of these patients was also not detected due to the lack and control of RT-PCR reagents at the early stage of COVID-19 epidemic in Wuhan. Although the COVID-19 putative receptor ACE2 is critical to virus infection, [25] its expression and abundance in neonates' respiratory system remains unknown.

All these questions still await future study. Additionally, the long-term follow-up is needed to evaluate physical and psychological development of these neonates.

In this study, we provided clinical features of SARS-CoV-2 infected women and reported health status of their fetuses. We observed no obvious vertical transmission between these mothers and their neonates, and suggested that immediate prevention measures should be taken for these patients and their neonates to avoid SARS-CoV-2 infections after birth. Lymphopenia and eosinopenia that were uncommon in normal pregnant women were observed at the onset of SARS-CoV-2 related symptoms, which might facilitate early recognition of COVID-19.

The authors declare no conflict of interest. 

Clinical characteristics and intrauterine vertical transmission potential of covid-19 infection in nine pregnant women: A retrospective review of medical records

National Institude for Viral Disease Control and Prevention. Specific primers and probes for detection 2019 novel coronavirus

Clinical management of severe acute respiratory infection when novel coronavirus (COVID-19) infection is suspected

National Health Commission of China. Clinical Diagnosis and treatment Guidance of 2019 novel coronavirus (COVID-19) caused pneumonia

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

SARS and other coronaviruses as causes of pneumonia

Immunity's pregnant pause

Pregnancy Associated with Systemic Lupus Erythematosus: Immune Tolerance in Pregnancy and Its Deficiency in Systemic Lupus Erythematosus--An Immunological Dilemma

Alternative theories: Pregnancy and immune tolerance

A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong

Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus. New Engl

Changes in circulating eosinophils in women during the menstrual cycle and reproduction

T and b lymphocytes during normal human pregnancy: A longitudinal study

Glucocorticoid-induced eosinopenia in humans can be linked to early transcriptional events

Analytical Review: The Mechanism of Glucocorticoid Eosinopenia

Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature

Severe acute respiratory syndrome (SARS) in neonates and children

Impact of Middle East Respiratory Syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

We would like to thank all healthcare workers who work in the frontline combatting against COVID-19, and all doctors and nurses who helped these SARS-CoV-2 infected women safely delivered their babies. This work is funded by the National Natural Science Foundation of China Wang analyzed and interpreted the data, drafted and revised the manuscript. Zehua Wang also has equally contributions to the data analyses and manuscript preparing.

Normal Apgar score (Score 10) 1-5-10min: 8-9-10 1-5-10min: 8-9-10 1-5-10min: 7-8-10 1-5-10min: 8-9-10 1-5-10min: 8-9-10